Leases

9 Months Ended

Sep. 30, 2021

As of September 30, 2021, the maturities of the Company’s operating lease liabilities and a reconciliation to the present value of lease liabilities were as follows (in thousands):


	Remaining Lease Payments
Remainder of 2021	$	1,859
2022	10,315
2023	9,910
2024	9,984
2025	6,558
Thereafter	64,802
Total remaining lease payments	103,428
Less: imputed interest	(24,104)
Total operating lease liabilities	79,324
Less: current portion	(6,988)
Long-term operating lease liabilities	$	72,336
Weighted-average remaining lease term (in years)	13.03
Weighted-average discount rate	4.0		%

The following summarizes additional supplemental data related to operating leases (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Operating lease costs	$	3,211	$	1,747	$	7,888	$	6,024


	Nine Months Ended September 30,
	2021		2020
Right-of-use assets obtained in exchange for operating lease liabilities	$	37,682	$	23,766
Cash paid for operating leases	$	5,773	$	5,101

In the third quarter of 2021, the Company's lease of its new laboratory and headquarters facility in Fort Myers, Florida commenced. As of September 30, 2021, the Company had paid approximately $25 million to the landlord for the construction of the underlying assets which was classified as a prepaid lease asset until the lease commenced in the third quarter of 2021 at which time the prepaid lease asset was included in the calculation of the right-of-use asset. As of September 30, 2021, the Company had paid approximately $14 million to the landlord for leasehold improvements, which are included in property and equipment, net, for its new laboratory and headquarters facility. As of September 30, 2021, approximately $3 million remained unpaid in a construction disbursement escrow account for final remaining disbursements to the landlord and remained in restricted cash on the Consolidated Balance Sheets.